| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jeffrey Stuart Peters | Sec;VP | 2026-08-19 | 31,105 | $4.15 | $129.09kSell |
| Ezio Bonvini | CSci;SVP | 2026-08-17 | 40,000 | $2.60 | $104.00kBuy |
| Thomas Spitznagel | Sr VP Technical Ops | 2026-02-15 | 5,520 | $1.71 | $9.44kSell |
| Ezio Bonvini | Sr VP Research CSO | 2026-02-15 | 6,433 | $1.71 | $11.00kSell |
| James Karrels | SVP and CFO | 2026-02-15 | 5,790 | $1.71 | $9.90kSell |
| Jeffrey Stuart Peters | Senior VP GC and Secretary | 2026-02-15 | 5,147 | $1.71 | $8.80kSell |
| Eric Blasius Risser | President and CEO | 2026-02-15 | 6,433 | $1.71 | $11.00kSell |
| Beth Ann Smith | VP Controller Treasurer | 2026-02-15 | 423 | $1.71 | $723.33Sell |
| Ezio Bonvini | Sr VP Research CSO | 2026-02-08 | 4,311 | $1.81 | $7.80kSell |
| Beth Ann Smith | VP Controller Treasurer | 2026-02-08 | 612 | $1.81 | $1.11kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Target N. V. Biotech | 15.59% | 9,929,963 | $37.73M | Insider |
| Tpg Group Holdings Sbs Advisors Inc | 3.47% | 2,208,762 | $8.39M | Insider |
| Scott Koenig | 3.40% | 2,165,915 | $8.23M | Insider |
| Alta Biopharma Partners III LP | 3.16% | 2,013,509 | $7.65M | Insider |
| Interwest Partners VIII LP | 3.00% | 1,908,716 | $7.25M | Insider |
| Edward Hurwitz | 2.75% | 1,752,820 | $6.66M | Insider |
| Arnold L. Oronsky | 2.68% | 1,708,716 | $6.49M | Insider |
| Kenneth Galbraith | 2.07% | 1,317,049 | $5.00M | Insider |
| James Karrels | 0.48% | 306,368 | $1.16M | Insider |
| Ezio Bonvini | 0.32% | 200,899 | $763.42k | Insider |